Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Case Rep ; 22: e932045, 2021 Jul 03.
Artigo em Inglês | MEDLINE | ID: mdl-34215716

RESUMO

BACKGROUND Biocompatible hemodialysis membranes have greatly advanced the treatment of renal failure. Synthetic polysulfone dialysis membranes are considered to be very biocompatible because of their low propensity to activate complement. However, these membranes can reduce platelet count through platelet activation, although the mechanism of this activation is unknown. CASE REPORT We report the case of an 82-year-old man with a history of chronic kidney disease with recurrent gastrointestinal bleeding and worsening renal function who was initiated on renal replacement therapy with polysulfone dialysis membranes. On admission, the patient's platelet count was normal at 233×10³/µL. A significant fall in platelet count was observed following most dialysis treatments, reaching a nadir of 37×10³/µL. With occasional dialysis treatments, his platelet count did not change. This dialysis-induced thrombocytopenia resolved following substitution with Cellentia-H cellulose triacetate single-use, hollow-fiber, high-flux hemodialyzer membrane. CONCLUSIONS Polysulfone membranes are capable of activating platelets, which can result in severe thrombocytopenia. However, the magnitude of dialysis-induced thrombocytopenia varies from treatment to treatment. As such, it may not be evident when the pre- and postdialysis platelet counts are measured for a single treatment. Because the etiology of this platelet activation is unknown, substitution with cellulose triacetate membranes should be considered. These membranes have an unrelated chemical composition and a very low propensity to activate platelets.


Assuntos
Diálise Renal , Trombocitopenia , Idoso de 80 Anos ou mais , Materiais Biocompatíveis , Humanos , Masculino , Membranas Artificiais , Polímeros , Sulfonas
2.
Acta Physiol (Oxf) ; 232(1): e13629, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33590667

RESUMO

AIM: We have reported earlier that a high salt intake triggered an aestivation-like natriuretic-ureotelic body water conservation response that lowered muscle mass and increased blood pressure. Here, we tested the hypothesis that a similar adaptive water conservation response occurs in experimental chronic renal failure. METHODS: In four subsequent experiments in Sprague Dawley rats, we used surgical 5/6 renal mass reduction (5/6 Nx) to induce chronic renal failure. We studied solute and water excretion in 24-hour metabolic cage experiments, chronic blood pressure by radiotelemetry, chronic metabolic adjustment in liver and skeletal muscle by metabolomics and selected enzyme activity measurements, body Na+ , K+ and water by dry ashing, and acute transepidermal water loss in conjunction with skin blood flow and intra-arterial blood pressure. RESULTS: 5/6 Nx rats were polyuric, because their kidneys could not sufficiently concentrate the urine. Physiological adaptation to this renal water loss included mobilization of nitrogen and energy from muscle for organic osmolyte production, elevated norepinephrine and copeptin levels with reduced skin blood flow, which by means of compensation reduced their transepidermal water loss. This complex physiologic-metabolic adjustment across multiple organs allowed the rats to stabilize their body water content despite persisting renal water loss, albeit at the expense of hypertension and catabolic mobilization of muscle protein. CONCLUSION: Physiological adaptation to body water loss, termed aestivation, is an evolutionary conserved survival strategy and an under-studied research area in medical physiology, which besides hypertension and muscle mass loss in chronic renal failure may explain many otherwise unexplainable phenomena in medicine.


Assuntos
Conservação dos Recursos Hídricos , Hipertensão , Falência Renal Crônica , Animais , Pressão Sanguínea , Rim , Masculino , Músculo Esquelético/fisiologia , Ratos , Ratos Sprague-Dawley
4.
Kidney Dis (Basel) ; 5(4): 204-210, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31768377

RESUMO

BACKGROUND: Graduate medical education varies in different countries. There is a general consensus in training methods, including residency and fellowship training systems. The graduate medical education system in western countries including the UK and the USA has been shown to be successful. The new graduate medical education training system in China was recently established and is still evolving and being implemented nationally. SUMMARY: This paper reviews the history of nephrology training programs in the USA, the role of the Accreditation Council for Graduate Medical Education (ACGME) in establishing and enforcing guidelines and curriculum for specialty training programs, the fellowship application and Match system for the recruitment of prospective fellows, and the quality control of fellowship training programs through rigorous evaluation and In-Training examination. This review specifically discusses the nephrology subspecialty fellowship and ACGME-accredited training programs in nephrology. The authors also provide several critical suggestions on the newly established postgraduate medical education training system in China, particularly in nephrology, based on experiences from successful US nephrology fellowship practices. KEY MESSAGES: The ACGME-accredited nephrology fellowship program has been shown to be effective and successful, which could provide an insight into the newly established graduate medical education training system in China. The authors are optimistic that reforms in Chinese medical training systems will be successful in the near future.

6.
J Vasc Access ; 18(2): 103-108, 2017 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-28165583

RESUMO

PURPOSE: Central venous catheters (CVC) are associated with increased infection rates, morbidity and mortality compared to other hemodialysis vascular access. Chlorhexidine-impregnated transparent (CHG-transparent) dressings allow for continuous antimicrobial exposure and easy visibility of the CVC insertion site. We conducted a quality improvement project to compare catheter-related infection (CRI) rates in two dressing regimens - CHG-transparent dressings and adhesive dry gauze dressing in hemodialysis patients with tunneled CVCs. METHODS: The study was conducted in two phases. In phase 1, CHG-transparent dressing was introduced to EDC hemodialysis unit, while EDG and EDN hemodialysis units, served as the control sites and maintained adhesive dry gauze dressing. Phase 2 of the study involved replacing the adhesive dry gauze dressing with CHG-transparent dressing at EDG and EDN and maintaining CHG-transparent dressing at EDC. CRI rates at each hemodialysis unit during the 12-month intervention were compared to CRI rates for the 12-month pre-intervention period for each study phase. CRI rates were also compared between all three hemodialysis units. RESULTS: In phase 1, CRI rates (per 1000 days) in EDC (intervention site) decreased by 52% (1.69 vs. 0.82, p<0.05) and increased by 12% (1.80 vs. 2.02, p = 0.75) at EDG, and 35% (0.91 vs. 1.23, p = 0.40) at EDN. In phase 2, CRI rates at EDG and EDN (intervention sites) decreased by 86% (1.86 vs. 0.26 p<0.05), and 53% (1.89 vs. 0.88, p<0.05), respectively, and decreased by 20% at EDC (0.73 vs. 0.58, p = 0.65). CONCLUSIONS: Replacing adhesive dry gauze dressing with CHG-transparent dressing for hemodialysis patients with tunneled CVC was associated with decreased CRI rates.


Assuntos
Anti-Infecciosos Locais/administração & dosagem , Bandagens , Infecções Relacionadas a Cateter/prevenção & controle , Cateterismo Venoso Central/efeitos adversos , Cateteres de Demora/efeitos adversos , Cateteres Venosos Centrais/efeitos adversos , Clorexidina/administração & dosagem , Indicadores de Qualidade em Assistência à Saúde , Diálise Renal , Idoso , Anti-Infecciosos Locais/efeitos adversos , Bandagens/efeitos adversos , Infecções Relacionadas a Cateter/diagnóstico , Infecções Relacionadas a Cateter/microbiologia , Cateterismo Venoso Central/instrumentação , Cateterismo Venoso Central/normas , Clorexidina/efeitos adversos , Feminino , Georgia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Melhoria de Qualidade/normas , Indicadores de Qualidade em Assistência à Saúde/normas , Diálise Renal/normas , Fatores de Risco , Fatores de Tempo , Resultado do Tratamento
7.
Physiol Rep ; 4(11)2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27273880

RESUMO

In humans, urea is excreted in sweat, largely through the eccrine sweat gland. The urea concentration in human sweat is elevated when compared to blood urea nitrogen. The sweat urea nitrogen (UN) of patients with end-stage kidney disease (ESRD) is increased when compared with healthy humans. The ability to produce sweat is maintained in the overwhelming majority of ESRD patients. A comprehensive literature review found no reports of sweat UN neither in healthy rodents nor in rodent models of chronic kidney disease (CKD). Therefore, this study measured sweat UN concentrations in healthy and uremic rats. Uninephrectomy followed by renal artery ligation was used to remove 5/6 of renal function. Rats were then fed a high-protein diet to induce uremia. Pilocarpine was used to induce sweating. Sweat droplets were collected under oil. Sweat UN was measured with a urease assay. Serum UN was measured using a fluorescent ortho-pthalaldehyde reaction. Immunohistochemistry (IHC) was accomplished with a horseradish peroxidase and diaminobenzidine technique. Sweat UN in uremic rats was elevated greater than two times compared to healthy pair-fed controls (220 ± 17 and 91 ± 15 mmol/L, respectively). Post hoc analysis showed a significant difference between male and female uremic sweat UN (279 ± 38 and 177 ± 11 mmol/L, respectively.) IHC shows, for the first time, the presence of the urea transporters UT-B and UT-A2 in both healthy and uremic rat cutaneous structures. Future studies will use this model to elucidate how rat sweat UN and other solute excretion is altered by commonly prescribed diuretics.


Assuntos
Proteínas de Membrana Transportadoras/metabolismo , Suor/química , Ureia/análise , Uremia/metabolismo , Animais , Proteínas Alimentares , Feminino , Masculino , Nefrectomia , Ratos , Ratos Sprague-Dawley , Uremia/induzido quimicamente , Transportadores de Ureia
8.
Am J Nephrol ; 40(2): 151-6, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25171490

RESUMO

Most pretransplant malignancies require a tumor-free waiting period before transplantation. End-stage renal disease (ESRD) patients have an increased risk of renal cell carcinoma (RCC), which is mostly detected from routine screening during pre-kidney transplant evaluation. RCC must be quiescent prior to kidney transplantation. However, the tumor-free waiting period for RCC varies depending on the types of RCC. Multilocular cystic RCC (MCRCC), one subtype of clear cell RCC, has low malignant potential and may not require a tumor-free waiting period. We report a case of an ESRD patient with a newly diagnosed MCRCC that was found during routine pre-kidney transplant evaluation. A plan for kidney transplantation within 6 months of successful tumor removal by nephrectomy was made. The literature regarding MCRCC in kidney transplantation is reviewed.


Assuntos
Carcinoma de Células Renais/patologia , Falência Renal Crônica/cirurgia , Neoplasias Renais/patologia , Transplante de Rim , Carcinoma de Células Renais/complicações , Carcinoma de Células Renais/cirurgia , Humanos , Falência Renal Crônica/complicações , Neoplasias Renais/complicações , Neoplasias Renais/cirurgia , Masculino , Pessoa de Meia-Idade , Nefrectomia , Fatores de Tempo
9.
Am J Physiol Renal Physiol ; 305(5): F645-52, 2013 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-23739593

RESUMO

Hypertension is a leading cause of morbidity and mortality worldwide, and disordered sodium balance has long been implicated in its pathogenesis. Aldosterone is perhaps the key regulator of sodium balance and thus blood pressure. The sodium chloride cotransporter (NCC) in the distal convoluted tubule of the kidney is a major site of sodium reabsorption and plays a key role in blood pressure regulation. Chronic exposure to aldosterone increases NCC protein expression and function. However, more acute effects of aldosterone on NCC are unknown. In our salt-abundant modern society where chronic salt deprivation is rare, understanding the acute effects of aldosterone is critical. Here, we examined the acute effects (12-36 h) of aldosterone on NCC in the rodent kidney and in a mouse distal convoluted tubule cell line. Studies demonstrated that aldosterone acutely stimulated NCC activity and phosphorylation without affecting total NCC abundance or surface expression. This effect was dependent upon the presence of the mineralocorticoid receptor and serum- and glucocorticoid-regulated kinase 1 (SGK1). Furthermore, STE20/SPS-1-related proline/alanine-rich kinase (SPAK) phosphorylation also increased, and gene silencing of SPAK eliminated the effect of aldosterone on NCC activity. Aldosterone administration via a minipump in adrenalectomized rodents confirmed an increase in NCC phosphorylation without a change in NCC total protein. These data indicate that acute aldosterone-induced SPAK-dependent phosphorylation of NCC increases individual transporter activity.


Assuntos
Aldosterona/farmacologia , Proteínas Serina-Treonina Quinases/fisiologia , Simportadores de Cloreto de Sódio/fisiologia , Adrenalectomia , Animais , Células Cultivadas , Proteínas Imediatamente Precoces/efeitos dos fármacos , Proteínas Imediatamente Precoces/metabolismo , Masculino , Camundongos , Fosforilação/efeitos dos fármacos , Proteínas Serina-Treonina Quinases/efeitos dos fármacos , Proteínas Serina-Treonina Quinases/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores de Mineralocorticoides/efeitos dos fármacos , Simportadores de Cloreto de Sódio/efeitos dos fármacos , Membro 3 da Família 12 de Carreador de Soluto/efeitos dos fármacos
10.
ISRN Endocrinol ; 2013: 329606, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23431467

RESUMO

Insulin resistance is a common finding in chronic kidney disease (CKD) and is manifested by mild fasting hyperglycemia and abnormal glucose tolerance testing. Circulating levels of glucocorticoids are high. In muscle, changes in the insulin signaling pathway occur. An increase in the regulatory p85 subunit of Class I phosphatidylinositol 3-Kinase enzyme leads to decreased activation of the downstream effector protein kinase B (Akt). Mechanisms promoting muscle proteolysis and atrophy are unleashed. The link of Akt to the ubiquitin proteasome pathway, a major degradation pathway in muscle, is discussed. Another factor associated with insulin resistance in CKD is angiotensin II (Ang II) which appears to induce its intracellular effects through inflammatory cytokines or reactive oxygen species. Skeletal muscle ATP is depleted and the ability of AMP-activated protein kinase (AMPK) to replenish energy stores is blocked. How this can be reversed is discussed. Interleukin-6 (IL-6) levels are elevated in CKD and impair insulin signaling at the level of IRS-1. With exercise, IL-6 levels are reduced; glucose uptake and utilization are increased. For patients with CKD, exercise may improve insulin signaling and build up muscle. Treatment strategies for preventing muscle atrophy are discussed.

11.
Am J Physiol Renal Physiol ; 301(6): F1314-25, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21921024

RESUMO

Pendrin is an anion exchanger expressed in the apical regions of B and non-A, non-B intercalated cells. Since angiotensin II increases pendrin-mediated Cl(-) absorption in vitro, we asked whether angiotensin II increases pendrin expression in vivo and whether angiotensin-induced hypertension is pendrin dependent. While blood pressure was similar in pendrin null and wild-type mice under basal conditions, following 2 wk of angiotensin II administration blood pressure was 31 mmHg lower in pendrin null than in wild-type mice. Thus pendrin null mice have a blunted pressor response to angiotensin II. Further experiments explored the effect of angiotensin on pendrin expression. Angiotensin II administration shifted pendrin label from the subapical space to the apical plasma membrane, independent of aldosterone. To explore the role of the angiotensin receptors in this response, pendrin abundance and subcellular distribution were examined in wild-type, angiotensin type 1a (Agtr1a) and type 2 receptor (Agtr2) null mice given 7 days of a NaCl-restricted diet (< 0.02% NaCl). Some mice received an Agtr1 inhibitor (candesartan) or vehicle. Both Agtr1a gene ablation and Agtr1 inhibitors shifted pendrin label from the apical plasma membrane to the subapical space, independent of the Agtr2 or nitric oxide (NO). However, Agtr1 ablation reduced pendrin protein abundance through the Agtr2 and NO. Thus angiotensin II-induced hypertension is pendrin dependent. Angiotensin II acts through the Agtr1a to shift pendrin from the subapical space to the apical plasma membrane. This Agtr1 action may be blunted by the Agtr2, which acts through NO to reduce pendrin protein abundance.


Assuntos
Proteínas de Transporte de Ânions/metabolismo , Hipertensão/metabolismo , Receptor Tipo 1 de Angiotensina/metabolismo , Aldosterona/farmacologia , Angiotensina II/farmacologia , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Animais , Benzimidazóis/farmacologia , Compostos de Bifenilo , Pressão Sanguínea/efeitos dos fármacos , Dieta Hipossódica , Feminino , Hipertensão/induzido quimicamente , Masculino , Camundongos , Óxido Nítrico/metabolismo , Receptor Tipo 1 de Angiotensina/genética , Receptor Tipo 2 de Angiotensina/metabolismo , Transportadores de Sulfato , Tetrazóis/farmacologia , Regulação para Cima , Vasoconstritores/farmacologia
12.
Adv Chronic Kidney Dis ; 17(4): 308-19, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20610358

RESUMO

The elderly population in the United States continues to grow and is expected to double by 2050. With aging, there are degenerative changes in many organs and the kidney is no exception. After 40 years of age, there is an increase in cortical glomerulosclerosis and a decline in both glomerular filtration rate and renal plasma flow. These changes may be associated with an inability to excrete a concentrated or a dilute urine, ammonium, sodium, or potassium. Hypernatremia and hyponatremia are the most common electrolyte abnormalities found in the elderly and both are associated with a high mortality. Under normal conditions, the elderly are able to maintain water and electrolyte balance, but this may be jeopardized by an illness, a decline in cognitive ability, and with certain medications. Therefore, it is important to be aware of the potential electrolyte abnormalities in the elderly that can arise under these various conditions to prevent adverse outcomes.


Assuntos
Envelhecimento/sangue , Eletrólitos/sangue , Sódio/sangue , Desequilíbrio Hidroeletrolítico/epidemiologia , Equilíbrio Ácido-Base , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Animais , Modelos Animais de Doenças , Humanos , Pessoa de Meia-Idade , Potássio/sangue , Equilíbrio Hidroeletrolítico , Desequilíbrio Hidroeletrolítico/etiologia
14.
Biochim Biophys Acta ; 1803(8): 960-7, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20359506

RESUMO

PGC-1alpha is a transcriptional coactivator that controls energy homeostasis through regulation of glucose and oxidative metabolism. Both PGC-1alpha expression and oxidative capacity are decreased in skeletal muscle of patients and animals undergoing atrophy, suggesting that PGC-1alpha participates in the regulation of muscle mass. PGC-1alpha gene expression is controlled by calcium- and cAMP-sensitive pathways. However, the mechanism regulating PGC-1alpha in skeletal muscle during atrophy remains unclear. Therefore, we examined the mechanism responsible for decreased PGC-1alpha expression using a rodent streptozotocin (STZ) model of chronic diabetes and atrophy. After 21days, the levels of PGC-1alpha protein and mRNA were decreased. We examined the activation state of CREB, a potent activator of PGC-1alpha transcription, and found that phospho-CREB was paradoxically high in muscle of STZ-rats, suggesting that the cAMP pathway was not involved in PGC-1alpha regulation. In contrast, expression of calcineurin (Cn), a calcium-dependent phosphatase, was suppressed in the same muscles. PGC-1alpha expression is regulated by two Cn substrates, MEF2 and NFATc. Therefore, we examined MEF2 and NFATc activity in muscles from STZ-rats. Target genes MRF4 and MCIP1.4 mRNAs were both significantly reduced, consistent with reduced Cn signaling. Moreover, levels of MRF4, MCIP1.4, and PGC-1alpha were also decreased in muscles of CnAalpha-/- and CnAbeta-/- mice without diabetes indicating that decreased Cn signaling, rather than changes in other calcium- or cAMP-sensitive pathways, were responsible for decreased PGC-1alpha expression. These findings demonstrate that Cn activity is a major determinant of PGC-1alpha expression in skeletal muscle during diabetes and possibly other conditions associated with loss of muscle mass.


Assuntos
Calcineurina/metabolismo , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patologia , Atrofia Muscular , Proteínas de Ligação a RNA/metabolismo , Transdução de Sinais/fisiologia , Transativadores/metabolismo , Fatores de Transcrição/metabolismo , Animais , Calcineurina/genética , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/genética , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/metabolismo , Complicações do Diabetes/metabolismo , Complicações do Diabetes/patologia , Diabetes Mellitus Experimental/genética , Humanos , Masculino , Camundongos , Músculo Esquelético/citologia , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Atrofia Muscular/etiologia , Atrofia Muscular/metabolismo , Atrofia Muscular/patologia , Fatores de Regulação Miogênica/genética , Fatores de Regulação Miogênica/metabolismo , Fatores de Transcrição NFATC/genética , Fatores de Transcrição NFATC/metabolismo , Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo , Proteínas de Ligação a RNA/genética , Ratos , Ratos Sprague-Dawley , Transativadores/genética , Fatores de Transcrição/genética , Transcrição Gênica
15.
Kidney Int ; 76(11): 1127-9, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19910948

RESUMO

The incidence of metabolic syndrome (MS) in renal transplant patients is unacceptably high. Dietary intake may ameliorate or worsen the potential for the development of MS. The choice of immunosuppression also plays a role. Continued effort to find beneficial dietary combinations is essential while ongoing research evolves to find newer immunosuppressive medications with less adverse metabolic side effects.


Assuntos
Dieta Mediterrânea , Humanos , Transplante de Rim , Síndrome Metabólica/prevenção & controle , Complicações Pós-Operatórias/prevenção & controle
16.
Kidney Int ; 76(7): 751-9, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19641484

RESUMO

Chronic kidney disease (CKD) impairs muscle protein metabolism leading to muscle atrophy, and exercise can counteract this muscle wasting. Here we evaluated how resistance exercise (muscle overload) and endurance training (treadmill running) affect CKD-induced abnormalities in muscle protein metabolism and progenitor cell function using mouse plantaris muscle. Both exercise models blunted the increase in disease-induced muscle proteolysis and improved phosphorylation of Akt and the forkhead transcription factor FoxO1. Muscle overloading, but not treadmill running, corrected protein synthesis and levels of mediators of protein synthesis such as phosphorylated mTOR and p70S6K in the muscles of mice with CKD. In these mice, muscle overload, but not treadmill, running, increased muscle progenitor cell number and activity as measured by the amounts of MyoD, myogenin, and eMyHC mRNAs. Muscle overload not only increased plantaris weight and reduced muscle proteolysis but also corrected intracellular signals regulating protein and progenitor cell function in mice with CKD. Treadmill running corrects muscle proteolysis but not protein synthesis or progenitor cell function. Our results provide a basis for evaluating different types of exercise on muscle atrophy in patients with chronic kidney disease.


Assuntos
Terapia por Exercício/métodos , Nefropatias/reabilitação , Proteínas Musculares/metabolismo , Condicionamento Físico Animal/métodos , Células-Tronco/patologia , Animais , Doença Crônica , Nefropatias/metabolismo , Nefropatias/patologia , Camundongos , Músculo Esquelético , Resistência Física , Resultado do Tratamento
17.
Nat Rev Nephrol ; 5(7): 418-22, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19556995

RESUMO

BACKGROUND: A 48-year-old woman with chronic urinary tract infections presented with uremia. Imaging studies revealed bilateral hydronephrosis and segmental ureteral thickening. INVESTIGATIONS: Physical examination, urine and blood analysis, radiography of the chest, chest CT, abdominal and pelvis CT, renal ultrasonography, cystoscopy, anterograde pyelogram, bladder biopsy. DIAGNOSIS: Malacoplakia involving bilatateral ureters and bladder; cavitary pneumonia. MANAGEMENT: Hemodialysis, placement of bilateral percutaneous nephrostomy tubes, administration of ciprofloxacin, ascorbic acid and bethanechol.


Assuntos
Malacoplasia/complicações , Malacoplasia/diagnóstico , Obstrução Ureteral/diagnóstico , Obstrução Ureteral/etiologia , Adulto , Doença Crônica , Feminino , Humanos , Hidronefrose/diagnóstico , Hidronefrose/etiologia , Hidronefrose/terapia , Obstrução Ureteral/terapia
18.
Semin Dial ; 22(5): 512-8, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19497033

RESUMO

Until recently, patients on dialysis with low serum albumin levels were characterized as suffering from protein malnutrition suggesting that the cause of this malady was due to an inadequate intake of protein. In fact, these patients tend to suffer from a wasting syndrome similar to cachexia commonly associated with inflammation in which there is loss of lean body mass and fat mass is underutilized. The term protein energy wasting has been used to characterize this syndrome and suggests that the simple addition of protein supplements to the dietary regimen of hemodialysis patients will not cure this malady. Correction of the underlying inflammatory disorder which drives losses of body protein and fuel reserves is far more important and is the single most effective therapy. Protein supplements which may promote albumin synthesis and synthesis of liver-related proteins tend to increase muscle catabolism. Muscle growth is not fostered by increasing dietary protein above recommended goals for dialysis patients, but can be promoted by the addition of protein of high biological value that is rich in leucine and other essential amino acids in tandem with repetitive exercises. Ultimately, correction of PEW hinges on the diagnosis and treatment of co-morbid conditions in combination with strategies to replenish caloric and protein stores. A supplementary exercise program would allow recovery of lean body mass. Given the multiple co-morbidities that exist in this population, therapy would have to be individualized.


Assuntos
Proteínas Alimentares/administração & dosagem , Suplementos Nutricionais , Desnutrição Proteico-Calórica/dietoterapia , Diálise Renal , Albuminas/fisiologia , Ingestão de Energia , Humanos , Músculo Estriado/metabolismo
19.
Kidney Int ; 74(2): 143-5, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18591943

RESUMO

Muscle wasting is a hallmark of uremic cachexia and has frequently been attributed to malnutrition that manifests as anorexia in chronic kidney disease. However, recent evidence indicates that proteolytic mechanisms are responsible for atrophy. Cheung and colleagues have reexamined the links between loss of lean body mass and nutrition. They demonstrate that neuropeptide signaling pathways, which regulate appetite and energy expenditure, also affect expression of key proteins involved in muscle mass maintenance.


Assuntos
Caquexia/metabolismo , Melanocortinas/metabolismo , Atrofia Muscular/metabolismo , Uremia/complicações , Animais , Regulação do Apetite , Caquexia/etiologia , Caquexia/prevenção & controle , Doença Crônica , Humanos , Leptina/metabolismo , Masculino , Melanocortinas/antagonistas & inibidores , Camundongos , Músculo Esquelético/metabolismo , Atrofia Muscular/etiologia , Atrofia Muscular/prevenção & controle , Necessidades Nutricionais , Transdução de Sinais
20.
J Nephrol ; 21 Suppl 13: S71-7, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18446736

RESUMO

BACKGROUND: Hemodialysis (HD) induces physiological changes that may affect the ability to dissipate heat and adversely affect sleep on the nights following treatment. We studied the effects of altering dialysate temperature on polysomnographic measures of nocturnal sleep and the time course of proximal skin temperature. METHODS: The sample included seven stable HD patients. The three-phase randomized trial was conducted in a research facility. After one acclimatization night, subjects were readmitted in the evening on two additional occasions for 42 hours and received HD the next morning in the warm condition (dialysate--37 degrees C) and cool condition (dialysate--35 degrees C) in random order. Continuous proximal skin temperature (axillary, Tax) and polysomnographic measures of sleep were recorded the nights before and after HD was administered. RESULTS: Highly significant findings included that the course of Tax was markedly affected by the interaction of time and condition. In addition, there was a greater drop of Tax in the early morning following the warm condition than during the baseline nights or in the cool condition. Logistic regression indicated that the odds for the occurrence of sleep and its deeper stages were strongly and positively associated with Tax. Time of sleep onset was earlier in the cool condition (p = 0.032) with trends toward longer total sleep times (p = 0.090) and shorter REM latencies (p = 0.088). CONCLUSIONS: These observations suggest that the use of cool dialysate during HD may improve nocturnal sleep the night following treatment by decreasing sympathetic activation and sustaining the normally elevated nocturnal skin temperature until later into the morning hours.


Assuntos
Regulação da Temperatura Corporal , Temperatura Baixa , Soluções para Hemodiálise , Diálise Renal/efeitos adversos , Distúrbios do Início e da Manutenção do Sono/prevenção & controle , Sono REM , Adulto , Estudos Cross-Over , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Polissonografia , Medição de Risco , Método Simples-Cego , Temperatura Cutânea , Distúrbios do Início e da Manutenção do Sono/etiologia , Distúrbios do Início e da Manutenção do Sono/fisiopatologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...